Owen B. John's most recent trade in Discover Financial Services was a trade of 1,308 Common Stock done at an average price of $201.1 . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Discover Financial | John B. Owen | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.09 per share. | 31 Jan 2025 | 1,308 | 21,360 (0%) | 0% | 201.1 | 263,026 | Common Stock |
| ImmunityBio Inc | John Owen Brennan | Director | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | ||
| Discover Financial | John B. Owen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,532 | 22,668 (0%) | 0% | 0 | Common Stock | |
| Discover Financial | B. Owen John | Director, Interim CEO and President | Grant, award, or other acquisition of securities at price $ 105.52 per share. | 31 Jan 2024 | 15,164 | 23,213 (0%) | 0% | 105.5 | 1,600,105 | Common Stock |
| Discover Financial | Owen B. John | Director, Interim CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.52 per share. | 31 Jan 2024 | 1,463 | 21,750 (0%) | 0% | 105.5 | 154,376 | Common Stock |
| Discover Financial | Owen B. John | Director, Interim CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.52 per share. | 31 Jan 2024 | 614 | 21,136 (0%) | 0% | 105.5 | 64,789 | Common Stock |
| Discover Financial | John B. Owen | Director, Interim CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 4,871 | 8,049 (0%) | 0% | 0 | Common Stock | |
| ImmunityBio Inc | John Owen Brennan | Director | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | ||
| ImmunityBio Inc | John Owen Brennan | Director | 02 Jun 2023 | 10,000 | 25,000 | - | 2.9 | 29,000 | Common Stock | |
| ImmunityBio Inc | John Owen Brennan | Director | 02 Jun 2023 | 10,000 | 15,000 | - | 2.8 | 28,000 | Common Stock | |
| ImmunityBio Inc | John Owen Brennan | Director | 02 Jun 2023 | 5,000 | 5,000 | - | 2.7 | 13,700 | Common Stock | |
| Discover Financial | John B. Owen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,774 | 3,178 (0%) | 0% | 0 | Common Stock | |
| ImmunityBio Inc | John Owen Brennan | Director | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | ||
| Discover Financial | John B. Owen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 1,404 | 1,404 (0%) | 0% | 0 | Common Stock | |
| ImmunityBio Inc | John Owen Brennan | Director | 10 Jun 2021 | 26,064 | 26,064 | - | - | Stock Option (right to buy) | ||
| ImmunityBio Inc | John Owen Brennan | Director | 03 May 2021 | 21,873 | 21,873 | - | - | Stock Option (right to buy) | ||
| Regions Financial | John B. Owen | SEVP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2021 | 6,000 | 24,187 (0%) | 0% | 0 | Common Stock | |
| Regions Financial | John B. Owen | SEVP & COO | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 05 Feb 2021 | 40,000 | 30,187 (0%) | 0% | 19.0 | 761,456 | Common Stock |
| Regions Financial | John B. Owen | SEVP & COO | Sale of securities on an exchange or to another person at price $ 17.73 per share. | 26 Jan 2021 | 75,000 | 70,187 (0%) | 0% | 17.7 | 1,329,938 | Common Stock |